High Mark Wealth Management LLC Y M Abs Therapeutics, Inc. Transaction History

High Mark Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$3.0 - $15.17 $1,500 - $7,585	-500 Reduced 69.44%	220 $1,000
Q1 2022 Apr 25, 2022	SELL	$6.55 - $17.42 $982 - $2,613	-150 Reduced 17.24%	720 $9,000
Q4 2021 Jan 20, 2022	SELL	$15.51 - $29.31 $3,613 - $6,829	-233 Reduced 21.12%	870 $14,000
Q3 2021 Nov 01, 2021	SELL	$27.47 - $37.31 $4,889 - $6,641	-178 Reduced 13.9%	1,103 $31,000
Q2 2021 Aug 02, 2021	BUY	$25.45 - $37.64 $23,668 - $35,005	930 Added 264.96%	1,281 $43,000
Q1 2021 Apr 22, 2021	SELL	$29.16 - $51.96 $874 - $1,558	-30 Reduced 7.87%	351 $11,000
Q4 2020 Jan 27, 2021	SELL	$37.86 - $54.26 $71,896 - $103,039	-1,899 Reduced 83.29%	381 $19,000
Q3 2020 Oct 26, 2020	BUY	$35.13 - $43.62 $71,700 - $89,028	2,041 Added 853.97%	2,280 $88,000
Q2 2020 Jul 22, 2020	BUY	$23.66 - $49.53 $5,654 - $11,837	239 New	239 $10,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.